http://vaccines.net/pneumoco.htm
Contact Congressman
Dan Burton's Office (Tel: 202-225-5074; Fax: 202-226-1274) if you want this
stopped You can email one
of his staff members Beth Clay beth.clay@mail.house.gov
New `Tuskegee-Like
Experiment' Planned with Pneumococcal Pneumonia Vaccine, Reported by Classen
Immunotherapies
BALTIMORE, Feb. 18 /PRNewswire/ -- The
following was released today by Classen Immunotherapies, Inc.:
The FDA cleared yesterday a controversial new
pneumococcal pneumonia vaccine with questionable safety and a US government
advisory panel is planning to selectively target black children and Native
American children for immunization. This plan is being criticized for making
children of certain racial minorities ``human guinea pigs''. It is possible
that 1% or more of the children who receive the vaccine may develop insulin
dependent diabetes or another autoimmune disease from the vaccine.
This week the Center for Disease Control
and Prevention's Advisory Committee on Immunization Practices recommended that
children under 2 receive the new pneumococcal vaccine but that black and Native
American children age 2-5 be selectively targeted for immunization. This policy
has come under criticism because the vaccine has never been properly tested for
safety and the FDA has been told by an expert that the vaccine is expected to
cause an epidemic of autoimmune disease.
The controversial vaccine is the
conjugated 7-valent pneumococcal vaccine which is really a combination of 7
different vaccines, each to a separate strain of pneumococcal pneumonia
bacteria. The vaccine is similar in structure to the already marketed
hemophilus meningitis vaccine, a vaccine linked to large epidemics of insulin
dependent diabetes.
Dr. J. Bart Classen, an immunologist at
Classen Immunotherapies, published data in the British Medical Journal (BMJ
1999; 319:1133) http://www.bmj.com/cgi/eletters/318/7192/1169
supporting a causal relationship between the hemophilus vaccine and the
development of insulin dependent diabetes. The vaccine has been incriminated in
causing over 58 cases of insulin dependent diabetes per 100,000 children
immunized in Finland. Dr. Classen told the FDA at a recent meeting that the 7
valent pneumococcal vaccine may be 7 times as toxic as the hemophilus vaccine,
possibly causing an estimated 400 to 700 children to develop insulin dependent
diabetes/100,000 children immunized. These cases of diabetes may not occur
until 3.5 to 10 years following immunization.
``The government's plan to selectively
target black and Native Americans is likely to have the effect of genocide,
0.5% of children who receive this vaccine may develop insulin dependent
diabetes from the vaccine and diabetes is just one of many life threatening
autoimmune disease,'' states Classen. ``I believe the vaccine clearly should
not have been approved by the FDA because it does not meet the criteria for
approval based on US law.''
Dr. Classen's research has been published
in numerous journals and featured in national news reports. For the latest
information on the effects of vaccines on insulin dependent diabetes and other
autoimmune diseases visit the Vaccine Safety Website.
Contact Congressman Dan
Burton's Office (Tel: 202-225-5074; Fax: 202-226-1274) if you want this stopped
You can email one of his
staff members Beth Clay beth.clay@mail.house.gov
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR
OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING
MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN
IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN
CONSULTATION WITH YOUR HEALTH CARE PROVIDER.